Pathologically, the c-Rel+ compared to the c-Rel− DLBCL group less frequently had Myc or pAKT overexpression, whereas more frequently expressed nuclear p50, p52 and RelB (Table 1). This evidence concerns the gene MYC and diffuse large B-cell lymphoma.